跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Flutixin 500 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Flutixin 500
Approved
STANDARD
Flutixin 500
Mepro Pharmaceuticals Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f565918649e28970
Company
Mepro Pharmaceuticals Private Limited
Type
Standard
Approval Details
Approval Id
f565918649e28970
Drug Approval Philippines Name
Flutixin 500
Product Name
Flutixin 500
Registration Number
DRP-10818
Brand Name
Flutixin 500
Generic Name
Salmeterol (as xinafoate) + Fluticasone propionate
Dosage Form
Dry Powder for Inhalation in Capsule
Dosage Strength
50 mcg/500 mcg
Manufacturer
Mepro Pharmaceuticals Private Limited
Importer
S.M.H.P. Marketing & Consultancy
Distributor
S.M.H.P. Marketing & Consultancy
Issuance Date
29 November 2021
Expiry Date
29 November 2026
Pharmacologic Category
Selective Beta-2-adrenoreceptor agonist/Corticosteroid
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f565918649e28970
Type
Standard
Back to Philippines FDA Approvals